Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03
/
mega-study
SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03